Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rectal and colon cancer: Not just a different anatomic site.
Tamas K, Walenkamp AM, de Vries EG, van Vugt MA, Beets-Tan RG, van Etten B, de Groot DJ, Hospers GA. Tamas K, et al. Cancer Treat Rev. 2015 Sep;41(8):671-9. doi: 10.1016/j.ctrv.2015.06.007. Epub 2015 Jun 28. Cancer Treat Rev. 2015. PMID: 26145760 Review.
Evaluation of short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical surgical treatment in primary stage IV rectal cancer.
van Dijk TH, Tamas K, Beukema JC, Beets GL, Gelderblom AJ, de Jong KP, Nagtegaal ID, Rutten HJ, van de Velde CJ, Wiggers T, Hospers GA, Havenga K. van Dijk TH, et al. Among authors: tamas k. Ann Oncol. 2013 Jul;24(7):1762-1769. doi: 10.1093/annonc/mdt124. Epub 2013 Mar 22. Ann Oncol. 2013. PMID: 23524865 Free article. Clinical Trial.
What do European community oncologists expect from the European Society for Medical Oncology? Results from a survey among community oncologists in Germany, Greece, Hungary, Italy, Luxembourg, Romania, and Spain.
Eckert R, Curca R, D'Addario G, Lanzetta G, Martorell PM, Mauri D, Rauh S, Schmitz S, Tamas K, Karamouzis MV. Eckert R, et al. Among authors: tamas k. Ann Oncol. 2013 May;24(5):1419-20. doi: 10.1093/annonc/mdt101. Epub 2013 Mar 15. Ann Oncol. 2013. PMID: 23504947 Free article. No abstract available.
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial.
Trøseid M, Arribas JR, Assoumou L, Holten AR, Poissy J, Terzić V, Mazzaferri F, Baño JR, Eustace J, Hites M, Joannidis M, Paiva JA, Reuter J, Püntmann I, Patrick-Brown TDJH, Westerheim E, Nezvalova-Henriksen K, Beniguel L, Dahl TB, Bouscambert M, Halanova M, Péterfi Z, Tsiodras S, Rezek M, Briel M, Ünal S, Schlegel M, Ader F, Lacombe K, Amdal CD, Rodrigues S, Tonby K, Gaudet A, Heggelund L, Mootien J, Johannessen A, Møller JH, Pollan BD, Tveita AA, Kildal AB, Richard JC, Dalgard O, Simensen VC, Baldé A, de Gastines L, Del Álamo M, Aydin B, Lund-Johansen F, Trabaud MA, Diallo A, Halvorsen B, Røttingen JA, Tacconelli E, Yazdanpanah Y, Olsen IC, Costagliola D; EU SolidAct study group. Trøseid M, et al. Crit Care. 2023 Jan 10;27(1):9. doi: 10.1186/s13054-022-04205-8. Crit Care. 2023. PMID: 36627655 Free PMC article. Clinical Trial.
Baseline Characteristics and Disease Phenotype in Inflammatory Bowel Disease.
Müller KE, Lakatos PL, Kovacs JB, Arato A, Varkonyi A, Nemes E, Tarnok A, Toth G, Papp M, Solyom E, Horvath A, Guthy I, Kovacs M, Veres G; Hungarian Pediatric IBD Registry Group. Müller KE, et al. J Pediatr Gastroenterol Nutr. 2016 Jan;62(1):50-5. doi: 10.1097/MPG.0000000000000885. J Pediatr Gastroenterol Nutr. 2016. PMID: 26192700
18 results